ST Germain D J Co. Inc. Has $9.15 Million Holdings in Align Technology, Inc. (NASDAQ:ALGN)

Share on StockTwits

ST Germain D J Co. Inc. lessened its stake in Align Technology, Inc. (NASDAQ:ALGN) by 47.4% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 27,959 shares of the medical equipment provider’s stock after selling 25,234 shares during the quarter. ST Germain D J Co. Inc.’s holdings in Align Technology were worth $9,153,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Morgan Stanley increased its stake in Align Technology by 43.3% during the first quarter. Morgan Stanley now owns 277,808 shares of the medical equipment provider’s stock valued at $48,325,000 after acquiring an additional 83,915 shares during the period. SG Americas Securities LLC increased its position in Align Technology by 15.1% in the second quarter. SG Americas Securities LLC now owns 9,807 shares of the medical equipment provider’s stock worth $2,691,000 after buying an additional 1,288 shares in the last quarter. CWM LLC grew its position in shares of Align Technology by 106.3% during the second quarter. CWM LLC now owns 13,002 shares of the medical equipment provider’s stock worth $3,568,000 after purchasing an additional 6,699 shares in the last quarter. Granite Investment Advisors LLC grew its position in shares of Align Technology by 7.8% during the second quarter. Granite Investment Advisors LLC now owns 1,250 shares of the medical equipment provider’s stock worth $343,000 after purchasing an additional 90 shares in the last quarter. Finally, Creative Planning grew its position in shares of Align Technology by 0.6% during the second quarter. Creative Planning now owns 7,642 shares of the medical equipment provider’s stock worth $2,097,000 after purchasing an additional 49 shares in the last quarter. Hedge funds and other institutional investors own 70.53% of the company’s stock.

In related news, Director Simon Beard sold 4,727 shares of the company’s stock in a transaction that occurred on Thursday, August 27th. The shares were sold at an average price of $307.19, for a total value of $1,452,087.13. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Joseph M. Hogan sold 5,700 shares of the company’s stock in a transaction that occurred on Thursday, August 27th. The shares were sold at an average price of $310.00, for a total transaction of $1,767,000.00. Following the completion of the sale, the chief executive officer now owns 194,036 shares of the company’s stock, valued at approximately $60,151,160. The disclosure for this sale can be found here. Insiders have sold 165,089 shares of company stock worth $73,298,611 over the last 90 days. 1.20% of the stock is currently owned by company insiders.

Shares of ALGN stock traded up $5.10 during trading hours on Friday, hitting $446.45. 560,109 shares of the company were exchanged, compared to its average volume of 968,762. The firm has a market cap of $35.20 billion, a PE ratio of 20.31, a PEG ratio of 7.54 and a beta of 1.75. Align Technology, Inc. has a 1 year low of $127.88 and a 1 year high of $507.05. The firm has a fifty day moving average of $403.17 and a 200 day moving average of $311.98.

Align Technology (NASDAQ:ALGN) last posted its earnings results on Wednesday, October 21st. The medical equipment provider reported $2.25 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.23 by $2.02. Align Technology had a net margin of 76.00% and a return on equity of 68.99%. The firm had revenue of $734.14 million during the quarter, compared to the consensus estimate of $551.55 million. During the same quarter in the prior year, the company earned $1.28 EPS. The company’s revenue was up 20.9% on a year-over-year basis. As a group, equities research analysts predict that Align Technology, Inc. will post 3.32 earnings per share for the current year.

A number of equities research analysts recently issued reports on ALGN shares. Robert W. Baird upped their price target on shares of Align Technology from $370.00 to $450.00 in a research note on Thursday, October 22nd. Stifel Nicolaus boosted their price objective on shares of Align Technology from $460.00 to $515.00 and gave the company a “buy” rating in a research report on Wednesday, October 28th. Berenberg Bank cut shares of Align Technology from a “buy” rating to a “hold” rating and set a $306.00 price target on the stock. in a report on Wednesday, July 29th. Credit Suisse Group upped their price target on shares of Align Technology from $348.00 to $432.00 and gave the stock an “outperform” rating in a report on Thursday, October 22nd. Finally, ValuEngine raised shares of Align Technology from a “sell” rating to a “hold” rating in a research note on Friday, October 23rd. One analyst has rated the stock with a sell rating, five have given a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $388.46.

Align Technology Profile

Align Technology, Inc, a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services.

Read More: Oversold

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.